COVID-19 Publications

Self-Assessed Severity as a Determinant of COVID-19 Symptom Specificity: A Longitudinal Cohort Study (Aug 2022)

Detection and Kinetics of Subgenomic Severe Acute Respiratory Syndrome Coronavirus 2 RNA Viral Load in Longitudinal Diagnostic RNA-Positive Samples (Sep 2022)

Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants (Sep 2022)

Durable immune response to Omicron subvariants following Novavax vaccine series and Pfizer boost (Jan 2024)

Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial (Aug 2023)

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants (Jul 2023)

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial (Apr 2023)

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant (Jul 2022)

Homologous and Heterologous COVID-19 Booster Vaccinations (Mar 2022)

A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS-CoV-2(-)/(+) populations (Jul 2023)

Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials (Mar 2023)

Using Time Weighted Average Change from Baseline of SARS-CoV-2 Viral Load to Assess Impact of HCQ as PEP and Early Treatment for COVID-19 (Dec 2022)

Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials (Jun 2023)

Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials (Feb 2022)

Trajectory of viral RNA load among persons with incident SARS-CoV-2 G614 infection (Wuhan strain) in relation to COVID-19 symptom onset and severity (Jan 2022)

A multifaceted high-throughput assay for probing antigen-specific antibody-mediated primary monocyte phagocytosis and downstream functions (Nov 2022)

CD8+ T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccination (Oct 2022)

T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity (May 2022)

T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components (Mar 2022)